Casein kinase 1α governs antigen-receptor-induced NF-κB activation and human lymphoma cell survival

Nicolas Bidère, Vu N. Ngo, Jeansun Lee, Cailin Collins, Lixin Zheng, Fengyi Wan, R. Eric Davis, Georg Lenz, D. Eric Anderson, Damien Arnoult, Aimé Vazquez, Keiko Sakai, Jun Zhang, Zhaojing Meng, Timothy D. Veenstra, Louis M. Staudt, Michael J. Lenardo

Research output: Contribution to journalArticle

Abstract

The transcription factor NF-κB is required for lymphocyte activation and proliferation as well as the survival of certain lymphoma types. Antigen receptor stimulation assembles an NF-κB activating platform containing the scaffold protein CARMA1 (also called CARD11), the adaptor BCL10 and the paracaspase MALT1 (the CBM complex), linked to the inhibitor of NF-κB kinase complex, but signal transduction is not fully understood. We conducted parallel screens involving a mass spectrometry analysis of CARMA1 binding partners and an RNA interference screen for growth inhibition of the CBM-dependent 'activated B-cell-like' (ABC) subtype of diffuse large B-cell lymphoma (DLBCL). Here we report that both screens identified casein kinase 1α (CK1α) as a bifunctional regulator of NF-κB. CK1α dynamically associates with the CBM complex on T-cell-receptor (TCR) engagement to participate in cytokine production and lymphocyte proliferation. However, CK1α kinase activity has a contrasting role by subsequently promoting the phosphorylation and inactivation of CARMA1. CK1α has thus a dual 'gating' function which first promotes and then terminates receptor-induced NF-κB. ABC DLBCL cells required CK1α for constitutive NF-κB activity, indicating that CK1α functions as a conditionally essential malignancy gene - a member of a new class of potential cancer therapeutic targets.

Original languageEnglish (US)
Pages (from-to)92-96
Number of pages5
JournalNature
Volume458
Issue number7234
DOIs
StatePublished - Mar 5 2009
Externally publishedYes

Fingerprint

Casein Kinase I
Antigen Receptors
Lymphoma
Cell Survival
Lymphoma, Large B-Cell, Diffuse
B-Lymphocytes
Phosphotransferases
Essential Genes
Lymphocyte Activation
T-Cell Antigen Receptor
RNA Interference
Signal Transduction
Mass Spectrometry
Neoplasms
Transcription Factors
Phosphorylation
Lymphocytes
Cytokines
Survival
Growth

ASJC Scopus subject areas

  • General

Cite this

Bidère, N., Ngo, V. N., Lee, J., Collins, C., Zheng, L., Wan, F., ... Lenardo, M. J. (2009). Casein kinase 1α governs antigen-receptor-induced NF-κB activation and human lymphoma cell survival. Nature, 458(7234), 92-96. https://doi.org/10.1038/nature07613

Casein kinase 1α governs antigen-receptor-induced NF-κB activation and human lymphoma cell survival. / Bidère, Nicolas; Ngo, Vu N.; Lee, Jeansun; Collins, Cailin; Zheng, Lixin; Wan, Fengyi; Davis, R. Eric; Lenz, Georg; Anderson, D. Eric; Arnoult, Damien; Vazquez, Aimé; Sakai, Keiko; Zhang, Jun; Meng, Zhaojing; Veenstra, Timothy D.; Staudt, Louis M.; Lenardo, Michael J.

In: Nature, Vol. 458, No. 7234, 05.03.2009, p. 92-96.

Research output: Contribution to journalArticle

Bidère, N, Ngo, VN, Lee, J, Collins, C, Zheng, L, Wan, F, Davis, RE, Lenz, G, Anderson, DE, Arnoult, D, Vazquez, A, Sakai, K, Zhang, J, Meng, Z, Veenstra, TD, Staudt, LM & Lenardo, MJ 2009, 'Casein kinase 1α governs antigen-receptor-induced NF-κB activation and human lymphoma cell survival', Nature, vol. 458, no. 7234, pp. 92-96. https://doi.org/10.1038/nature07613
Bidère, Nicolas ; Ngo, Vu N. ; Lee, Jeansun ; Collins, Cailin ; Zheng, Lixin ; Wan, Fengyi ; Davis, R. Eric ; Lenz, Georg ; Anderson, D. Eric ; Arnoult, Damien ; Vazquez, Aimé ; Sakai, Keiko ; Zhang, Jun ; Meng, Zhaojing ; Veenstra, Timothy D. ; Staudt, Louis M. ; Lenardo, Michael J. / Casein kinase 1α governs antigen-receptor-induced NF-κB activation and human lymphoma cell survival. In: Nature. 2009 ; Vol. 458, No. 7234. pp. 92-96.
@article{f1c9d78187714effa0d7c20e534f5477,
title = "Casein kinase 1α governs antigen-receptor-induced NF-κB activation and human lymphoma cell survival",
abstract = "The transcription factor NF-κB is required for lymphocyte activation and proliferation as well as the survival of certain lymphoma types. Antigen receptor stimulation assembles an NF-κB activating platform containing the scaffold protein CARMA1 (also called CARD11), the adaptor BCL10 and the paracaspase MALT1 (the CBM complex), linked to the inhibitor of NF-κB kinase complex, but signal transduction is not fully understood. We conducted parallel screens involving a mass spectrometry analysis of CARMA1 binding partners and an RNA interference screen for growth inhibition of the CBM-dependent 'activated B-cell-like' (ABC) subtype of diffuse large B-cell lymphoma (DLBCL). Here we report that both screens identified casein kinase 1α (CK1α) as a bifunctional regulator of NF-κB. CK1α dynamically associates with the CBM complex on T-cell-receptor (TCR) engagement to participate in cytokine production and lymphocyte proliferation. However, CK1α kinase activity has a contrasting role by subsequently promoting the phosphorylation and inactivation of CARMA1. CK1α has thus a dual 'gating' function which first promotes and then terminates receptor-induced NF-κB. ABC DLBCL cells required CK1α for constitutive NF-κB activity, indicating that CK1α functions as a conditionally essential malignancy gene - a member of a new class of potential cancer therapeutic targets.",
author = "Nicolas Bid{\`e}re and Ngo, {Vu N.} and Jeansun Lee and Cailin Collins and Lixin Zheng and Fengyi Wan and Davis, {R. Eric} and Georg Lenz and Anderson, {D. Eric} and Damien Arnoult and Aim{\'e} Vazquez and Keiko Sakai and Jun Zhang and Zhaojing Meng and Veenstra, {Timothy D.} and Staudt, {Louis M.} and Lenardo, {Michael J.}",
year = "2009",
month = "3",
day = "5",
doi = "10.1038/nature07613",
language = "English (US)",
volume = "458",
pages = "92--96",
journal = "Nature",
issn = "0028-0836",
publisher = "Nature Publishing Group",
number = "7234",

}

TY - JOUR

T1 - Casein kinase 1α governs antigen-receptor-induced NF-κB activation and human lymphoma cell survival

AU - Bidère, Nicolas

AU - Ngo, Vu N.

AU - Lee, Jeansun

AU - Collins, Cailin

AU - Zheng, Lixin

AU - Wan, Fengyi

AU - Davis, R. Eric

AU - Lenz, Georg

AU - Anderson, D. Eric

AU - Arnoult, Damien

AU - Vazquez, Aimé

AU - Sakai, Keiko

AU - Zhang, Jun

AU - Meng, Zhaojing

AU - Veenstra, Timothy D.

AU - Staudt, Louis M.

AU - Lenardo, Michael J.

PY - 2009/3/5

Y1 - 2009/3/5

N2 - The transcription factor NF-κB is required for lymphocyte activation and proliferation as well as the survival of certain lymphoma types. Antigen receptor stimulation assembles an NF-κB activating platform containing the scaffold protein CARMA1 (also called CARD11), the adaptor BCL10 and the paracaspase MALT1 (the CBM complex), linked to the inhibitor of NF-κB kinase complex, but signal transduction is not fully understood. We conducted parallel screens involving a mass spectrometry analysis of CARMA1 binding partners and an RNA interference screen for growth inhibition of the CBM-dependent 'activated B-cell-like' (ABC) subtype of diffuse large B-cell lymphoma (DLBCL). Here we report that both screens identified casein kinase 1α (CK1α) as a bifunctional regulator of NF-κB. CK1α dynamically associates with the CBM complex on T-cell-receptor (TCR) engagement to participate in cytokine production and lymphocyte proliferation. However, CK1α kinase activity has a contrasting role by subsequently promoting the phosphorylation and inactivation of CARMA1. CK1α has thus a dual 'gating' function which first promotes and then terminates receptor-induced NF-κB. ABC DLBCL cells required CK1α for constitutive NF-κB activity, indicating that CK1α functions as a conditionally essential malignancy gene - a member of a new class of potential cancer therapeutic targets.

AB - The transcription factor NF-κB is required for lymphocyte activation and proliferation as well as the survival of certain lymphoma types. Antigen receptor stimulation assembles an NF-κB activating platform containing the scaffold protein CARMA1 (also called CARD11), the adaptor BCL10 and the paracaspase MALT1 (the CBM complex), linked to the inhibitor of NF-κB kinase complex, but signal transduction is not fully understood. We conducted parallel screens involving a mass spectrometry analysis of CARMA1 binding partners and an RNA interference screen for growth inhibition of the CBM-dependent 'activated B-cell-like' (ABC) subtype of diffuse large B-cell lymphoma (DLBCL). Here we report that both screens identified casein kinase 1α (CK1α) as a bifunctional regulator of NF-κB. CK1α dynamically associates with the CBM complex on T-cell-receptor (TCR) engagement to participate in cytokine production and lymphocyte proliferation. However, CK1α kinase activity has a contrasting role by subsequently promoting the phosphorylation and inactivation of CARMA1. CK1α has thus a dual 'gating' function which first promotes and then terminates receptor-induced NF-κB. ABC DLBCL cells required CK1α for constitutive NF-κB activity, indicating that CK1α functions as a conditionally essential malignancy gene - a member of a new class of potential cancer therapeutic targets.

UR - http://www.scopus.com/inward/record.url?scp=62049084688&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=62049084688&partnerID=8YFLogxK

U2 - 10.1038/nature07613

DO - 10.1038/nature07613

M3 - Article

VL - 458

SP - 92

EP - 96

JO - Nature

JF - Nature

SN - 0028-0836

IS - 7234

ER -